Educational research on US and Indian equities, ETFs, mutual funds and crypto, with screeners and a free investing academy.
All data is for educational purposes only and should not be considered investment advice.
Equiscale is operated by Syntellia LLC, a Delaware limited liability company.
© 2026 Syntellia LLC. All rights reserved.
Brookdale Senior Living Inc. owns, manages, and operates senior living communities in the United States. It operates in three segments: Independent Living, Assisted Living and Memory Care, and Continuing Care Retirement Communities (CCRCs). The Independent Living segment owns or leases communities comprising independent and assisted living units in a single community that are primarily designed for middle to upper income seniors. The Assisted Living and Memory Care segment owns or leases communities consisting of freestanding, multi-story communities and freestanding single-story communities, which offer housing and 24-hour assistance with activities of daily living for the Company's residents. This segment operates memory care communities for residents with Alzheimer's and other dementias. The CCRCs segment owns or leases communities that provides various living arrangements, such as independent and assisted living, memory care, and skilled nursing; and services to accommodate various levels of physical ability and healthcare needs. It manages communities on behalf of others. The company was incorporated in 2005 and is headquartered in Brentwood, Tennessee.
Rule-based from financial data. Not advice.
5-year financial trends. Figures in USD millions.
Latest fiscal year: 2025
Year-by-year revenue, profitability, and cash flow (USD millions, last 5 years)
| Year | Revenue | EBITDA | Net Profit | FCF | ROE | Rev Growth 1Y | NP Growth 1Y |
|---|---|---|---|---|---|---|---|
| 2025 | $3.2B | $344M | $-263M | $17M | 587.0% | 2.2% | 30.1% |
| 2024 | $3.1B | $413M | $-202M | $-35M | -95.0% | 3.9% | 6.8% |
| 2023 | $3.0B | $402M | $-189M | $-70M | -46.8% | 9.5% | -20.7% |
| 2022 | $2.7B | $320M | $-238M | $-194M | -40.9% | - | - |
| 2021 | - |
Income statement, balance sheet, and cash flow as reported
Consolidated Figures in USD Millions.
| Metric | 2025 |
|---|---|
| Total Revenue | 3,194.07 |
| Operating Revenue | 3,053.56 |
| Cost Of Revenue | 2,356.52 |
| Gross Profit | 837.55 |
| Operating Expense | 750.93 |
| Selling General And Administration | 395.40 |
| Total Expenses | 3,107.45 |
| Operating Income | 86.62 |
| Total Operating Income As Reported | 13.50 |
| EBITDA | 343.94 |
| Normalized EBITDA | 458.28 |
| EBIT | -26.36 |
| Interest Income | 12.38 |
| Interest Expense | 238.34 |
| Net Interest Income | -240.73 |
| Other Non Operating Income Expenses | 3.80 |
| Other Income Expense | -110.54 |
| Interest Income Non Operating | 12.38 |
| Interest Expense Non Operating | 238.34 |
| Net Non Operating Interest Income Expense | -240.73 |
| Pretax Income | -264.70 |
| Tax Provision | -1.95 |
| Tax Rate For Calcs | 0 |
| Tax Effect Of Unusual Items | -0.80 |
| Net Income Continuous Operations | -262.75 |
| Net Income From Continuing And Discontinued Operation | -262.69 |
| Net Income From Continuing Operation Net Minority Interest | -262.69 |
| Net Income | -262.69 |
| Net Income Common Stockholders | -262.69 |
| Net Income Including Noncontrolling Interests | -262.75 |
| Normalized Income | -149.15 |
| Diluted NI Availto Com Stockholders | -262.69 |
| Basic Average Shares | 235.18 |
| Diluted Average Shares | 235.18 |
| Reconciled Depreciation | 370.30 |
| Reconciled Cost Of Revenue | 2,341.74 |
| Total Unusual Items | -114.34 |
| Total Unusual Items Excluding Goodwill | -114.34 |
| Minority Interests | 0.05 |
| Special Income Charges | -113.16 |
| Other Special Charges | 44.23 |
| Write Off | 0 |
| Impairment Of Capital Assets | 71.30 |
| Gain On Sale Of Security | -1.18 |
| Depreciation Amortization Depletion Income Statement | 355.53 |
| Depreciation And Amortization In Income Statement | 355.53 |
| General And Administrative Expense | 395.40 |
| Other Gand A | 195.14 |
| Salaries And Wages | - |
| Gain On Sale Of Ppe | 2.37 |
| Rent Expense Supplemental | 200.26 |
| Total Other Finance Cost | 14.78 |
| Other Operating Expenses | - |
| Rent And Landing Fees | 200.26 |
| Earnings From Equity Interest | 0 |
Healthcare sector peers, ranked by market cap
| Company | Ticker | Market Cap | P/E | P/B | ROE | EV/EBITDA |
|---|---|---|---|---|---|---|
| Brookdale Senior Living Inc.this co. | BKD | $2.8B | -10.81 | -63.45 | 587.0% | 23.48 |
| Warby Parker Inc. | WRBY | $3.0B | 1803.71 | 8.05 | 0.4% | 64.67 |
| LifeStance Health Group, Inc. | LFST | $2.9B | 301.90 | 1.92 | 0.6% | 39.90 |
| Adaptive Biotechnologies Corporation | ADPT | $2.9B | - | 13.23 | -27.2% | - |
| GRAIL, Inc. | GRAL |
| - |
| - |
| - |
| - |
| - |
| - |
| $2.9B |
| -6.99 |
| 1.11 |
| -15.8% |
| -7.04 |
| Soleno Therapeutics, Inc. | SLNO | $2.8B | 132.26 | 6.14 | 4.6% | 96.72 |
| Arcutis Biotherapeutics, Inc. | ARQT | $2.7B | -170.10 | 14.49 | -8.5% | 1582.53 |
| Disc Medicine, Inc. | IRON | $2.7B | -12.80 | 3.67 | -28.7% | -12.77 |
| Definium Therapeutics, Inc. | DFTX | $2.7B | -14.59 | 8.07 | -55.3% | -13.82 |
| Peer Median | - | -6.99 | 7.09 | -12.2% | 39.90 | |